RESEARCH TRIANGLE PARK, NC, November 01, 2022 (GLOBE NEWSWIRE) — Science 37 Holdings, Inc. SNCEthe Agile Clinical Trial Operating System™, announced today that it will report third quarter 2022 financial results after the market close on Thursday, November 10, 2022. Management will host a related conference call on Friday, November 11, 2022 at 8:30 am Eastern Time.
You can access the conference call by registering online for dial-in information or via live audio webcast at: https://investors.science37.com/news-events/events-presentations. Participants wishing to dial into the conference call are asked to register one day in advance or at least 15 minutes prior to the start of the conference call in order to receive a unique PIN for the conference call.
A replay of the conference call will be available via webcast for on-demand listening at the same web link shortly after the conclusion of the conference call and will remain available for approximately 90 days.
About science 37
Science37 Holdings, Inc SNCE Its mission is to enable universal access to clinical research, make it easy for patients and providers to participate from anywhere, and help accelerate the development of treatments that impact patients’ lives. A pioneer of decentralized clinical trials, the Science 37 l Operating System (OS) supports today’s more agile clinical research designs with its comprehensive end-to-end technology platform and centralized networks of patient communities, telemedical investigators, mobile nurses, remote coordinators, provider communities and data and Devices. Configurable for nearly any study type, the Science 37 OS enables up to 21x faster enrollment, 28% better patient retention, and a 3x more diverse patient population with industry-leading workflow orchestration, evidence generation, and data harmonization. For more information visit https://www.science37.com.
Contacts:
MEDIA INQUIRIES:
Drawn bustos
science 37
Phone: (610) 417-6953
E-mail: pr@science37.com
INVESTOR RELATIONS:
Steve Halper
